Correction: Thymosin beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
[This corrects the article DOI: 10.1371/journal.pone.0110598.].
Saved in:
| Main Author: | PLOS ONE Staff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0118428&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Methylsulfonylmethane on Hemodynamics and Oxidative Stress in Monocrotaline-Induced Pulmonary Hypertensive Rats
by: Sadollah Mohammadi, et al.
Published: (2012-01-01) -
Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01) -
Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
by: Olga Rafikova, et al.
Published: (2016-01-01) -
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection
by: Rui Yu, et al.
Published: (2021-01-01) -
The Correlation between Lung Ultrasound and Pathology in Rat Model of Monocrotaline-Induced Pulmonary Hypertension
by: Yan-Fen Zhong, et al.
Published: (2024-01-01)